Search

everythinglearnresearchcommunity

for

Search:↓

Using healthy donor stem cells can potentially calm overactive immune cells and reduce inflammation in severe hair loss patients, offering a possible treatment method.

Elidel combined with tretinoin is more effective for treating alopecia areata than Elidel alone.

Skin-resident memory T cells may contribute to chronic alopecia areata and baricitinib could be a potential treatment.

Emerging therapies like JAK inhibitors show promise for hair regrowth in alopecia areata.

Abrocitinib at 100 mg and 200 mg daily may significantly improve moderate-to-severe atopic dermatitis in patients 12 years and older.

CS12192 effectively treats alopecia areata with better safety than current options.

Primary care doctors need to monitor JAK and TYK-2 inhibitors carefully for skin conditions.

Cetuximab often causes skin rashes, and managing these is important for cancer treatment.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

Checkpoint inhibitor therapy can cause skin issues, from mild rashes to severe reactions.

Intramuscular corticosteroids are effective and safe for severe alopecia areata, with most patients regrowing hair, but nearly half may relapse.

Diphencyprone is effective for treating patchy hair loss in alopecia areata, but tacrolimus is not.

Topical tofacitinib is a safe and effective treatment for autoimmune skin disorders.

SCD-153 shows promise as an effective topical treatment for alopecia areata.

ASC-CM is more effective than EV for treating osteoarthritis.

A new mix of anthralin and calcipotriene might help treat severe hair loss.

Ruxolitinib reduced inflammation and improved symptoms in APECED patients but may cause anemia and weight gain.

Megestrol acetate helps fat-derived stem cells grow, move, and turn into fat cells through a specific receptor.

A woman's eyelash regrowth was successful using tofacitinib solution for alopecia areata.

Dermatologists are crucial for managing skin side effects in metastatic melanoma patients using vemurafenib and ipilimumab.

New micelle nanocarriers deliver Tacrolimus more effectively to skin layers for psoriasis treatment than the current Protopic ointment.

Longer treatment with vismodegib lowers relapse risk in basal cell carcinoma.

Upadacitinib helped regrow hair and maintain ulcerative colitis remission.

Standard dosing is more effective for severe alopecia areata in children, but unorthodox dosing can be safe and considered if needed.

Various dermatologic treatments were effective for skin conditions like acne, rosacea, hair loss, and psoriasis from December 1986 to December 1987.

Upadacitinib improved Crohn's disease, atopic dermatitis, and alopecia areata in one patient.

The ointment effectively treats neurodermatitis and chronic eczema without causing skin irritation.

Janus kinase inhibitors may effectively treat severe alopecia areata unresponsive to other treatments.

New drugs for rheumatoid arthritis show improvement but have side effects and are not a cure.

Baricitinib is more effective than methotrexate for severe alopecia areata.